Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast

Clinica Chimica Acta

Volumn 256, Issue 2, 1996, Pages 175-188

  Powell, Michael ^a   Prentice, Louise ^a   Asawa, Takayuki ^a   Kato, Ryoji ^a   Sawicka, Joanna ^a   Tanaka, Hideaki ^a   Petersen, Vaughan ^a   Munkley, Andrea ^a   Morgan, Sharon ^a   Rees Smith, Bernard ^b   Furmaniak, Jadwiga ^b  

^a RSR LTD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Autoimmunity; Glutamic acid decarboxylase; Insulin dependent diabetes mellitus; Islet cell antibodies; Saccharomyces cerevisiae

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; RECOMBINANT ENZYME;

ADDISON DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DIAGNOSIS; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; TECHNIQUE; YEAST;

ADULT; AGED; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FUNGAL PROTEINS; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOASSAY; INFANT; IODINE RADIOISOTOPES; MIDDLE AGED; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SUBSTRATE SPECIFICITY;

SACCHAROMYCES CEREVISIAE;

EID: 0030607713     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06422-4     Document Type: Article

References (29)

1. [1] Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-156.
2. [2] Falorni A, Kockum I, Sanjeevi CB, Lernmark Å. Pathogenesis of insulin-dependent diabetes mellitus. Baillière's Clin Endocrinol Metab 1995;9:25-46.
3. 65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994;43:459-467.
4. [4] Grubin CE, Daniels T, Toivola B et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344-350.
5. 65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 1994;37:917-924.
6. [6] Vandewalle CL, Falorni A, Svanholm S et al. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995;80:846-851.
7. 2-terminal domain. J Cell Biol 1992;118:309-320.
8. [8] Beever K, Bradbury J, Phillips D et al. Highly sensitive assays of autoantibodies to thyroglobulin and thyroid peroxidase. Clin. Chem 1989;35:1949-1954.
9. [9] Southgate K, Creagh F, Teece M, Kingwood C, Rees Smith, B. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol 1984;20:539-548.
10. [10] Vincent A, Newsom Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatr 1985;48:1246-1252.
11. [11] Colls J, Betterle C, Volpato M, Prentice L, Rees Smith B, Furmaniak J. Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases. Clin Chem 1995;41:375-380.
12. [12] Diabetes Mellitus. Report of a WHO study Group, Geneva, Switzerland 1985. WHO Technical Report Series, No. 727.
13. [13] Schuller HJ, Entian KD. Molecular characterization of yeast regulatory gene CAT3 necessary for glucose depression and nuclear localization of its product. Gene 1988;67:247-257.
14. [14] Ito H, Jukuda Y, Murata K, Kimura A. Transformation of intact yeast cells treated with alkali cations. J Bacteriol 1983;153:163-168.
15. 65 as the main immunogenic isoform of glutamate decarboxylase in Type I diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest 1993;91:2084-2090.
16. [16] Takino H, Kawasaki E, Yano M et al. The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase. J Autoimmun 1994;7:389-398.
17. [17] Moody AJ, Hejnæs KR, Marshall MO et al. Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells. Diabetologia 1995;38:14-23.
18. 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963;89:114-123.
19. [19] Rowley MJ, Mackay IR, Chen Q-Y, Knowles WJ, Zimmet PZ. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992;41:548-551.
20. [20] Bradford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
21. [21] Birk HW, Koepsell H. Reaction of monoclonal antibodies with plasma membrane proteins after binding on nitrocellulose: renaturation of antigenic sites and reduction of non-specific antibody binding. Anal Biochem 1987;164:12-22.
22. [22] Chang Y-C, Gottlieb DI. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci 1988;8:2123-2130.
23. [23] Smith DB, Corcoran LM. Expression and purification of glutathione-5-transferase fusion proteins. Curr Protocols Mol Biol 1994;2:16.7.1-16.7.7.
24. [24] Verge CF, Howard NJ, Rowley MJ et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994;37:1113-1120.
25. [25] Seissler J, Bieg S, Yassin N, Mauch L et al. Association between antibodies to the MR 67000 isoform of glutamate decarboxylase (GAD) and type I (insulin-dependent) diabetes mellitus with co-existing autoimmune polyendocrine syndrome type II. Autoimmunity 1994;19:231-238.
26. 67 precede the onset of Type I diabetes. Autoimmunity 1994;19:71-80.
27. [27] Yano M, Moriuchi R, Kawasaki E et al. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM). J Autoimmun 1995;8:83-96.
28. [28] Bonifacio E, Genovese S, Braghi S et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995;38:816-822.
29. [29] Kawasaki E, Abiru N, Yano M et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995;8:633-643.